Journal
ORAL DISEASES
Volume 12, Issue 5, Pages 436-442Publisher
BLACKWELL PUBLISHING
DOI: 10.1111/j.1601-0825.2006.01290.x
Keywords
glucocorticoids; adrenal insufficiency; inhaled corticosteroids; steroid supplementation; hypothalamic-pituitary-adrenal axis
Categories
Funding
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008831, ZIAHD000638, ZIEHD008832] Funding Source: NIH RePORTER
- EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [Z01HD000638, Z01HD008831, Z01HD008832] Funding Source: NIH RePORTER
- Intramural NIH HHS Funding Source: Medline
Ask authors/readers for more resources
Glucocorticoids can cause adverse systemic side-effects ranging from iatrogenic Cushing's syndrome during treatment, to hypothalamic-pituitary-adrenal axis suppression and clinically significant adrenal insufficiency when the agents are discontinued. While the oral route of administration is most often implicated, it is now becoming more apparent that inhaled and topical administration also can cause these effects. Given the high therapeutic value of glucocorticoids, the ability to prescribe these agents while maintaining a low risk-to-benefit ratio for patients is critical. The aim of this review is to provide oral healthcare practitioners with a practical guide to commonly used glucocorticoids, their adverse effects, and perioperative use.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available